Researchers found preoperative blood glucose levels were associated with hospital length of stay for patients undergoing laparoscopic nephrectomy for RCC.
The approval was based on data from an open-label phase 2 study which evaluated the efficacy and safety of Welireg in patients with von Hippel-Lindau-associated renal cell carcinoma and other VHL-associated tumors.
Researchers concluded that pembrolizumab plus axitinib may be the most effective first-line immunotherapy for mRCC
Decisions of how to proceed when positive surgical margins are found after partial nephrectomy are left to the discretion of the surgeon.
Researchers applied a 27-gene classifier proven effective with breast, lung, and bladder cancers to predict efficacy of ICI therapy in patients with RCC.
Compared with men, women had significant 18% lower odds of undertreatment and 27% higher odds of overtreatment of kidney cancer, according to a study.
A retrospective study identified factors that influenced overtreatment and undertreatment among patients with kidney cancer.
Systematic review and meta-analysis assessed the impact of delayed surgical intervention on localized and metastatic renal cell carcinoma.
The combination of lenvatinib and pembrolizumab improved health-related quality of life.
A meta-analysis of phase 3 randomized control trials sought to identify the TRAEs associated with 7 therapeutic regimens for the treatment of mRCC.
